Precision pharmacotherapy: psychiatry’s future direction in preventing, diagnosing, and treating mental disorders
Open accessThe DOI matches its Crossref record; 181 of the 184 references it cites were found in a registry or an index.
Abstract
Mental disorders account for around one-third of disability worldwide and cause enormous personal and societal burden. Current pharmacotherapies and nonpharmacotherapies do help many patients, but there are still high rates of partial or no response, delayed effect, and unfavorable adverse effects. The current diagnostic taxonomy of mental disorders by the Diagnostic and Statistical Manual of Mental Disorders and the International Classification of Diseases relies on presenting signs and symptoms, but does not reflect evidence from neurobiological and behavioral systems. However, in the last decades, the understanding of biological mechanisms underlying mental disorders has grown and can be used for the development of precision medicine, that is, to deliver a patient-tailored individual treatment. Precision medicine may incorporate genetic variants contributing to the mental disorder and the response to pharmacotherapies, but also consider gene ¥ environment interactions, blood-based markers, neuropsychological tests, data from electronic health records, early life adversity, stressful life events, and very proximal factors such as lifestyle, nutrition, and sport. Methods such as artificial intelligence and the underlying machine learning and deep learning approaches provide the framework to stratify patients, initiate specific tailored treatments and thus increase response rates, reduce adverse effects and medical errors. In conclusion, precision medicine uses measurable health parameters to identify individuals at risk of a mental disorder, to improve the diagnostic process and to deliver a patient-tailored treatment. Keywords: precision medicine, personalized medicine, biomarker, mental health, depression, childhood trauma, FKBP5, machine learning
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These findings again support the notion that drugs with very narrow specific mechanisms are only effective in patients with corresponding pathophysiology and that a matching of patients with treatment options using biomarkers or genetic markers is necessary [14].”
From The HPA Axis as Target for Depression (2024) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To match the patient with the right treatment approach in terms of an individualized treatment, it is necessary to apply tests that assess the function of the HPA axis, such as the dex-CRH test or the molecular DST [14, 47].”
From The HPA Axis as Target for Depression (2024) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatologist-level classification of skin cancer with deep neural networks
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017) · Nature · doi:10.1038/nature21056 · Cited by 14,362
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., & Wang, P. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09091379 · Cited by 7,067 · cited 3×
“In addition, the current diagnostic frameworks with Diagnostic and Statistical Manual of Mental Disorders (DSM) published by the American Psychiatric Association and the International Classification of Diseases (ICD) developed by the World Health Organization rely on presenting signs and symptoms but fail to align wit…”
MethodKirschbaum, C., Pirke, K.-M., & Hellhammer, D. H. (2008) · Neuropsychobiology · doi:10.1159/000119004 · Cited by 6,093
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800389 · Cited by 3,616
Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases
Pedersen, B. K., & Saltin, B. (2015) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/sms.12581 · Cited by 3,514
The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses
Hofmann, S. G., Asnaani, A., Vonk, I. J. J., Sawyer, A. T., & Fang, A. (2012) · Cognitive Therapy and Research · doi:10.1007/s10608-012-9476-1 · Cited by 3,445 · cited 1×
“Moreover, current drug treatment options are successful only in about half of the patients,(149) and similar considerations apply to nonpharmacologic treatment options such as psychotherapy.(150) There are many reasons for this unfavorable condition; the brain is the most complex organ in the body, and mental disorder…”
BackgroundPsychological Stress and Disease
Cohen, S., Janicki-Deverts, D., & Miller, G. E. (2007) · JAMA · doi:10.1001/jama.298.14.1685 · Cited by 3,168 · cited 3×
“Not only mental disorders are impacted by stress but also cardiovascular disorders or cancer is associated with psychological stress.(73) A prominent example of how psychological stress is affecting cardiovascular function was observed in 2006 during the World Cup Soccer in Germany, where cardiovascular events were si…”
BackgroundInfluentialToward the future of psychiatric diagnosis: the seven pillars of RDoC
Cuthbert, B. N., & Insel, T. R. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-126 · Cited by 3,053 · cited 4×
“In addition, the current diagnostic frameworks with Diagnostic and Statistical Manual of Mental Disorders (DSM) published by the American Psychiatric Association and the International Classification of Diseases (ICD) developed by the World Health Organization rely on presenting signs and symptoms but fail to align wit…”
BackgroundMethodInfluential(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010
eQTLGen, Wray, N. R., 23andMe, the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Ripke, S., Mattheisen, M., Trzaskowski, M., Byrne, E. M., Abdellaoui, A., Adams, M. J., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0090-3 · Cited by 3,005 · cited 1×
“Just recently, the PGC published a GWAS meta-analysis based on 1,35,458 cases and revealed 44 independent and significant loci.(27) A similar pattern could be observed analyzing schizophrenia cohorts, a mental disorder with higher heritability.”
MethodGenome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Heim, C., & Nemeroff, C. B. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01157-x · Cited by 2,791
Mediterranean diet pyramid: a cultural model for healthy eating
Willett, W., Sacks, F., Trichopoulou, A., Drescher, G., Ferro-Luzzi, A., Helsing, E., & Trichopoulos, D. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.6.1402s · Cited by 2,461
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388
Grand challenges in global mental health
Collins, P. Y., Patel, V., Joestl, S. S., March, D., Insel, T. R., Daar, A. S., Bordin, I. A., Costello, E. J., Durkin, M., Fairburn, C., et al. (2011) · Nature · doi:10.1038/475027a · Cited by 2,043
Analysis of shared heritability in common disorders of the brain
The Brainstorm Consortium, Anttila, V., Bulik-Sullivan, B., Finucane, H. K., Walters, R. K., Bras, J., Duncan, L., Escott-Price, V., Falcone, G. J., Gormley, P., et al. (2018) · Science · doi:10.1126/science.aap8757 · Cited by 1,924
Genome-wide association study identifies five new schizophrenia loci
The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011) · Nature Genetics · doi:10.1038/ng.940 · Cited by 1,919
Prevalence and Treatment of Mental Disorders, 1990 to 2003
Kessler, R. C., Demler, O., Frank, R. G., Olfson, M., Pincus, H. A., Walters, E. E., Wang, P., Wells, K. B., & Zaslavsky, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa043266 · Cited by 1,910
The global burden of mental disorders: An update from the WHO World Mental Health (WMH) surveys
Kessler, R. C., Aguilar-Gaxiola, S., Alonso, J., Chatterji, S., Lee, S., Ormel, J., Üstün, T. B., & Wang, P. S. (2009) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00001421 · Cited by 1,895 · cited 1×
“Current situation and potential for precision medicine Mental disorders are among the most detrimental disorders worldwide.(1) In Europe”
BackgroundThe rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770 · cited 3×
“Deep learning, another paradigm of machine learning, has meanwhile been successful in various artificial intelligence research areas such as language processing, speech recognition, self-driving cars, or computer vision.(166) Artificial intelligence systems are supposed to acquire data, combine data, and then perform…”
BackgroundMethodInfluentialPersonal genomes: The case of the missing heritability
Maher, B. (2008) · Nature · doi:10.1038/456018a · Cited by 1,737 · cited 1×
“detect the individual genetic variants that account for much of the heritability, which was termed missing heritability.(20)”
BackgroundCost of disorders of the brain in Europe 2010
Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.008 · Cited by 1,723
Shickel, B., Tighe, P. J., Bihorac, A., & Rashidi, P. (2018) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2017.2767063 · Cited by 1,688
The support of human genetic evidence for approved drug indications
Nelson, M. R., Tipney, H., Painter, J. L., Shen, J., Nicoletti, P., Shen, Y., Floratos, A., Sham, P. C., Li, M. J., Wang, J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3314 · Cited by 1,666 · cited 1×
“Many efforts are meanwhile in place to translate these genome-wide association findings into new drug targets for mental disorders or to repurpose existing drugs for the treatment of mental disorders that were not initially developed to treat, an approach called drug repositioning.(30,31) For example, the gene HMGCR w…”
BackgroundRaison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Sofi, F., Abbate, R., Gensini, G. F., & Casini, A. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29673 · Cited by 1,605
Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies
Wittchen, H.-U., & Jacobi, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.012 · Cited by 1,503 · cited 2×
“However, less than one-third of all patients receive any treatment in Europe.(3) The suicide rate is higher than the annual mortality from AIDS, most forms of cancer, and homicide.”
BackgroundAllele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions
Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J. C., Pariante, C. M., Pace, T. W. W., Mercer, K. B., Mayberg, H. S., Bradley, B., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3275 · Cited by 1,447
Common variants at 30 loci contribute to polygenic dyslipidemia
Kathiresan, S., Willer, C. J., Peloso, G. M., Demissie, S., Musunuru, K., Schadt, E. E., Kaplan, L., Bennett, D., Li, Y., Tanaka, T., et al. (2009) · Nature Genetics · doi:10.1038/ng.291 · Cited by 1,364
Childhood adversity and adult psychiatric disorder in the US National Comorbidity Survey
KESSLER, R. C., DAVIS, C. G., & KENDLER, K. S. (1997) · Psychological Medicine · doi:10.1017/s0033291797005588 · Cited by 1,298
Preventive strategies for mental health
Arango, C., Díaz-Caneja, C. M., McGorry, P. D., Rapoport, J., Sommer, I. E., Vorstman, J. A., McDaid, D., Marín, O., Serrano-Drozdowskyj, E., Freedman, R., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30057-9 · Cited by 1,271 · cited 1×
“Healthy lifestyle: nature, nutrition, and sport In contrast, there are also protective factors that ameliorate the risk to develop a mental disorder, such as social support, nutrition, or exposure to natural environments.(75,76) For example, walking or staying in a forest could decrease measures of depressive symptoms…”
BackgroundChildhood maltreatment predicts adult inflammation in a life-course study
Danese, A., Pariante, C. M., Caspi, A., Taylor, A., & Poulton, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610362104 · Cited by 1,264
Exercise treatment for depression
Dunn, A. L., Trivedi, M. H., Kampert, J. B., Clark, C. G., & Chambliss, H. O. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2004.09.003 · Cited by 1,208
Hunger, S. P., Lu, X., Devidas, M., Camitta, B. M., Gaynon, P. S., Winick, N. J., Reaman, G. H., & Carroll, W. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8018 · Cited by 1,180
Genetic architectures of psychiatric disorders: the emerging picture and its implications
Sullivan, P. F., Daly, M. J., & O'Donovan, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3240 · Cited by 1,177 · cited 1×
“The heritability estimates of the major mental disorders derived from large twin studies ranges from 40% of major depressive disorder (MDD) and posttraumatic stress disorder (PTSD) to 80% of schizophrenia, bipolar disorder, and attention-deficit hyperactivity disorder (ADHD).(17,18) The advances in genetics are couple…”
BackgroundCPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
Relling, M. V., & Klein, T. E. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.279 · Cited by 1,164 · cited 2×
“116,117 Genetic variants within these genes have been repeatedly associated with patients’ metabolizer phenotype118,119 and subsequently have been included in dosing guidelines for antidepressants by expert groups such as the Clinical Pharmacogenetics Implementation Consortium.120 Genetic variants within CYP2D6 and CY…”
A mega-analysis of genome-wide association studies for major depressive disorder
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke, S., Wray, N. R., Lewis, C. M., Hamilton, S. P., Weissman, M. M., Breen, G., Byrne, E. M., Blackwood, D. H. R., Boomsma, D. I., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.21 · Cited by 1,120
Precision Medicine — Personalized, Problematic, and Promising
Jameson, J. L., & Longo, D. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmsb1503104 · Cited by 1,106
Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap
Gandal, M. J., Haney, J. R., Parikshak, N. N., Leppa, V., Ramaswami, G., Hartl, C., Schork, A. J., Appadurai, V., Buil, A., Werge, T. M., et al. (2018) · Science · doi:10.1126/science.aad6469 · Cited by 1,095 · cited 2×
“A shared molecular pathology across the major mental disorders was also observed using transcriptomic profiling from cerebral postmortem tissue of patients with MDD, bipolar disorder, autism, schizophrenia, and alcoholism.(35) In this approach, a degree of shared but also distinct gene-expression perturbations across…”
BackgroundJacka, F. N., O’Neil, A., Opie, R., Itsiopoulos, C., Cotton, S., Mohebbi, M., Castle, D., Dash, S., Mihalopoulos, C., Chatterton, M. L., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0791-y · Cited by 1,093
Building better biomarkers: brain models in translational neuroimaging
Woo, C.-W., Chang, L. J., Lindquist, M. A., & Wager, T. D. (2017) · Nature Neuroscience · doi:10.1038/nn.4478 · Cited by 1,056 · cited 1×
“a second step the generalization performance is evaluated on test data, also called out of sample.(163) Especially, in mental”
BackgroundBinder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977
Binder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968 · cited 2×
“FKBP5 is another pharmacodynamics gene that has been associated with treatment response to antidepressants.(60) Interestingly, the genetic variant that was related to a dysregulated HPA axis was also associated with a beneficial response to antidepressants.”
Backgroundvan den Bosch, M., & Ode Sang, Å. (2017) · Environmental Research · doi:10.1016/j.envres.2017.05.040 · Cited by 968
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
Reducing Suicide--A National Imperative
(2002) · PsycEXTRA Dataset · doi:10.1037/e719942007-001 · Cited by 902
Pace, T. W. W., Mletzko, T. C., Alagbe, O., Musselman, D. L., Nemeroff, C. B., Miller, A. H., & Heim, C. M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1630 · Cited by 810
Association of Western and Traditional Diets With Depression and Anxiety in Women
Jacka, F. N., Pasco, J. A., Mykletun, A., Williams, L. J., Hodge, A. M., O'Reilly, S. L., Nicholson, G. C., Kotowicz, M. A., & Berk, M. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09060881 · Cited by 802
Machine Learning for Precision Psychiatry: Opportunities and Challenges
Bzdok, D., & Meyer-Lindenberg, A. (2018) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.11.007 · Cited by 796 · cited 4×
“In contrast, machine learning uncovers general concepts underlying a series of observations without explicit instructions.(161,162) Machine learning concepts include”
BackgroundInfluentialMediterranean diet, stroke, cognitive impairment, and depression: A meta‐analysis
Psaltopoulou, T., Sergentanis, T. N., Panagiotakos, D. B., Sergentanis, I. N., Kosti, R., & Scarmeas, N. (2013) · Annals of Neurology · doi:10.1002/ana.23944 · Cited by 793
Lai, J. S., Hiles, S., Bisquera, A., Hure, A. J., McEvoy, M., & Attia, J. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.069880 · Cited by 786
Hyde, C. L., Nagle, M. W., Tian, C., Chen, X., Paciga, S. A., Wendland, J. R., Tung, J. Y., Hinds, D. A., Perlis, R. H., & Winslow, A. R. (2016) · Nature Genetics · doi:10.1038/ng.3623 · Cited by 784 · cited 1×
“First significant hits were delivered by Hyde et al investigating self-reported MDD in 75,607 cases; this study identified 15 significantly associated loci.(26) Just recently, the PGC published a GWAS meta-analysis based on 1,35,458 cases and revealed 44 independent and significant loci.”
Relationship Between Diet and Mental Health in Children and Adolescents: A Systematic Review
O’Neil, A., Quirk, S. E., Housden, S., Brennan, S. L., Williams, L. J., Pasco, J. A., Berk, M., & Jacka, F. N. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.302110 · Cited by 734
Psychiatric Genomics: An Update and an Agenda
Sullivan, P. F., Agrawal, A., Bulik, C. M., Andreassen, O. A., Børglum, A. D., Breen, G., Cichon, S., Edenberg, H. J., Faraone, S. V., Gelernter, J., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17030283 · Cited by 676
Nusslock, R., & Miller, G. E. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.017 · Cited by 672
Kappelmann, N., Lewis, G., Dantzer, R., Jones, P. B., & Khandaker, G. M. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.167 · Cited by 659
Prevalence and Treatment of Mental Disorders
(2005) · New England Journal of Medicine · doi:10.1056/nejmc051936 · Cited by 650 · cited 1×
“In contrast to several other severe medical conditions, such as heart disease or cancer,(147) mortality has not decreased for any mental disorder, and the prevalence rates are similarly unchanged.(148) Moreover, current drug treatment options are successful only in about half of the patients,(149) and similar consider…”
BackgroundExercise programs for people with dementia
Forbes, D., Forbes, S. C., Blake, C. M., Thiessen, E. J., & Forbes, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006489.pub4 · Cited by 631
A systematic review and meta-analysis of exercise interventions in schizophrenia patients
Firth, J., Cotter, J., Elliott, R., French, P., & Yung, A. R. (2015) · Psychological Medicine · doi:10.1017/s0033291714003110 · Cited by 600
Nutritional medicine as mainstream in psychiatry
Sarris, J., Logan, A. C., Akbaraly, T. N., Amminger, G. P., Balanzá-Martínez, V., Freeman, M. P., Hibbeln, J., Matsuoka, Y., Mischoulon, D., Mizoue, T., et al. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00051-0 · Cited by 592
Prediction as a Humanitarian and Pragmatic Contribution from Human Cognitive Neuroscience
Gabrieli, J. D. E., Ghosh, S. S., & Whitfield-Gabrieli, S. (2015) · Neuron · doi:10.1016/j.neuron.2014.10.047 · Cited by 535 · cited 1×
“can be successful in a certain patient and unsuccessful in another patient, both labeled with the identical diagnosis.(151) Furthermore, antidepressants are used to treat not only”
BackgroundEcological momentary assessment of mood disorders and mood dysregulation
Ebner-Priemer, U. W., & Trull, T. J. (2009) · Psychological Assessment · doi:10.1037/a0017075 · Cited by 530 · cited 1×
“Nearly every person uses permanently the smartphone, and via extraction of smartphone data, many studies could show the acceptability and the feasibility of this approach to monitor patients’ behavior via ecological momentary assessments to predict alterations in mood and risk of the occurrence of a mental disorder.(1…”
BackgroundSurguladze, S. A., Young, A. W., Senior, C., Brébion, G., Travis, M. J., & Phillips, M. L. (2004) · Neuropsychology · doi:10.1037/0894-4105.18.2.212 · Cited by 525 · cited 1×
“Experimental evidence suggests that patients suffering from MDD are more likely to interpret facial expressions of emotion more negative than matched healthy controls.(143) Furthermore, it has been shown that treatment with antidepressants alters the processing of emotional information, for example, by causing depress…”
BackgroundThe longitudinal effects of depression on physical activity
Roshanaei-Moghaddam, B., Katon, W. J., & Russo, J. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.04.002 · Cited by 512
Effect of Acute Antidepressant Administration on Negative Affective Bias in Depressed Patients
Harmer, C. J., O’Sullivan, U., Favaron, E., Massey-Chase, R., Ayres, R., Reinecke, A., Goodwin, G. M., & Cowen, P. J. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020149 · Cited by 485 · cited 1×
“Furthermore, it has been shown that treatment with antidepressants alters the processing of emotional information, for example, by causing depressed patients to identify facial expressions as more positive.(144) Moreover, these cognitive effects of antidepressants can be detected early in the course of treatment and m…”
BackgroundZannas, A. S., Arloth, J., Carrillo-Roa, T., Iurato, S., Röh, S., Ressler, K. J., Nemeroff, C. B., Smith, A. K., Bradley, B., Heim, C., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0828-5 · Cited by 469 · cited 1×
“Next, combining genome-wide DNA methylation and gene expression data before and after GR activation revealed dynamic changes in methylation of the cytosine pyrimidine ring in cytosine/guanine (CpG) dinucleotides and transcription of gene neighboring epigenetic clock CpGs associated with aging and aging-related disorde…”
BackgroundSelf-citationAssociation between plasma IL-6 response to acute stress and early-life adversity in healthy adults
Carpenter, L. L., Gawuga, C. E., Tyrka, A. R., Lee, J. K., Anderson, G. M., & Price, L. H. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.159 · Cited by 464
Predicting healthcare trajectories from medical records: a deep learning approach
Pham, T., Tran, T., Phung, D., & Venkatesh, S. (2017) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2017.04.001 · Cited by 447
Morita, E., Fukuda, S., Nagano, J., Hamajima, N., Yamamoto, H., Iwai, Y., Nakashima, T., Ohira, H., & Shirakawa, T. (2007) · Public Health · doi:10.1016/j.puhe.2006.05.024 · Cited by 439
Cardiovascular Events during World Cup Soccer
Wilbert-Lampen, U., Leistner, D., Greven, S., Pohl, T., Sper, S., Völker, C., Güthlin, D., Plasse, A., Knez, A., Küchenhoff, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707427 · Cited by 428
Uher, R., Tansey, K. E., Dew, T., Maier, W., Mors, O., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010094 · Cited by 418
Kendler, K. S., Davis, C. G., & Kessler, R. C. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.6.541 · Cited by 412
Psychiatric genetics and the structure of psychopathology
Smoller, J. W., Andreassen, O. A., Edenberg, H. J., Faraone, S. V., Glatt, S. J., & Kendler, K. S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-017-0010-4 · Cited by 398 · cited 1×
“common and rare genetic variants contributing to several mental disorders.(17,19) Studies with small sample size failed to”
BackgroundPsychoneuroimmunology of early-life stress: the hidden wounds of childhood trauma?
Danese, A., & J Lewis, S. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.198 · Cited by 393 · cited 1×
“Subsequently, it leads to an increased sensitivity of the HPA axis and to low-grade inflammation with a heightened inflammatory response to subsequent stressors.(42,43) This is complemented with facilitated self-medicating behaviors like smoking, drug use, and consumption of highfat and high-sugar diets that subsequen…”
BackgroundUhr, M., Tontsch, A., Namendorf, C., Ripke, S., Lucae, S., Ising, M., Dose, T., Ebinger, M., Rosenhagen, M., Kohli, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2007.11.017 · Cited by 382
Physiological Effects of Nature Therapy: A Review of the Research in Japan
Song, C., Ikei, H., & Miyazaki, Y. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13080781 · Cited by 374
Epigenetics of Stress-Related Psychiatric Disorders and Gene × Environment Interactions
Klengel, T., & Binder, E. B. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.036 · Cited by 353
Manji, H. K., Moore, G. J., & Chen, G. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00979-3 · Cited by 352
An updated meta-analysis of oxidative stress markers in bipolar disorder
Brown, N. C., Andreazza, A. C., & Young, L. T. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.04.005 · Cited by 335
Individualized Medicine from Prewomb to Tomb
Topol, E. J. (2014) · Cell · doi:10.1016/j.cell.2014.02.012 · Cited by 333 · cited 1×
“The assessment of the genetic makeup, environmental factors including lifestyle, and markers derived from the stress systems also delivers predictors to identify individuals at risk; thus, precision medicine will also set up preventive strategies to reduce the risk of developing a mental disorder.(16)”
BackgroundPorcelli, S., Fabbri, C., & Serretti, A. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.10.003 · Cited by 331 · cited 1×
“Genetic variants within the promoter of the serotonin transporter gene (SLC6A4), which is a main key regulator of antidepressant mechanisms, have been repeatedly associated with treatment response to antidepressants.(123) Consistent evidence also suggests an involvement of other serotonin-related genetic variants, nam…”
BackgroundCure therapeutics and strategic prevention: raising the bar for mental health research
Insel, T. R., & Scolnick, E. M. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001777 · Cited by 313 · cited 2×
“Therefore, the National Institute of Mental Health started the Research Domain Criteria (RDoC) project to establish a research classification system for mental disorders that is based on neurobiological findings and observational behavior.(7,8,14) Implementing these RDocs into biomarker research is now progressively e…”
MethodIsing, M., Lucae, S., Binder, E. B., Bettecken, T., Uhr, M., Ripke, S., Kohli, M. A., Hennings, J. M., Horstmann, S., Kloiber, S., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.95 · Cited by 306
Self-citationDepressive Symptom Outcomes of Physical Activity Interventions: Meta-analysis Findings
Conn, V. S. (2010) · Annals of Behavioral Medicine · doi:10.1007/s12160-010-9172-x · Cited by 295
Wolfers, T., Buitelaar, J. K., Beckmann, C. F., Franke, B., & Marquand, A. F. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.08.001 · Cited by 290
Mocking, R. J. T., Harmsen, I., Assies, J., Koeter, M. W. J., Ruhé, H. G., & Schene, A. H. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.29 · Cited by 279
Pedersen, B. K., Pedersen, M., Krabbe, K. S., Bruunsgaard, H., Matthews, V. B., & Febbraio, M. A. (2009) · Experimental Physiology · doi:10.1113/expphysiol.2009.048561 · Cited by 255
Kessler, R. C., van Loo, H. M., Wardenaar, K. J., Bossarte, R. M., Brenner, L. A., Cai, T., Ebert, D. D., Hwang, I., Li, J., de Jonge, P., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.198 · Cited by 254 · cited 1×
“lifetime MDD and could generate a risk stratification for subsequent hospitalization or suicide attempt based on baseline self-reports.(165) Deep learning, another paradigm of machine learning, has meanwhile been successful in various artificial intelligence research areas such as language processing, speech recogniti…”
MethodContribution of Common Genetic Variants to Antidepressant Response
Tansey, K. E., Guipponi, M., Hu, X., Domenici, E., Lewis, G., Malafosse, A., Wendland, J. R., Lewis, C. M., McGuffin, P., & Uher, R. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.030 · Cited by 246
Grosso, G., Micek, A., Marventano, S., Castellano, S., Mistretta, A., Pajak, A., & Galvano, F. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.011 · Cited by 244
Torkamani, A., Andersen, K. G., Steinhubl, S. R., & Topol, E. J. (2017) · Cell · doi:10.1016/j.cell.2017.08.007 · Cited by 241 · cited 1×
“Artificial intelligence systems are supposed to acquire data, combine data, and then perform tasks and support decisions independent of humans.(167) Deep learning takes advantage of the increased amounts of data and computer power which enables multilayer feed-forward networks, that is, artificial neural networks with…”
BackgroundMoving towards a population health approach to the primary prevention of common mental disorders
Jacka, F. N., Mykletun, A., & Berk, M. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-149 · Cited by 235
The Effect of Paroxetine on 5-HT2A Receptors in Depression: An [18F]Setoperone PET Imaging Study
Meyer, J. H., Kapur, S., Eisfeld, B., Brown, G. M., Houle, S., DaSilva, J., Wilson, A. A., Rafi-Tari, S., Mayberg, H. S., & Kennedy, S. H. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.1.78 · Cited by 231
Matosin, N., Halldorsdottir, T., & Binder, E. B. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.021 · Cited by 226 · cited 3×
“This upregulation activates an ultrashort feedback loop, it activates the GR, and thus induces FKBP5 expression which limits the GR activity by binding to the GR complex.(41) Interestingly, this increase in FKBP5 RNA and protein is moderated by common genetic variants and specific epigenetic alterations present in sub…”
BackgroundInfluentialKuhlman, K. R., Chiang, J. J., Horn, S., & Bower, J. E. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.020 · Cited by 208
Ideno, Y., Hayashi, K., Abe, Y., Ueda, K., Iso, H., Noda, M., Lee, J.-S., & Suzuki, S. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1912-z · Cited by 201
Mehta, D. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.50 · Cited by 200 · cited 1×
“Applying the mDST in a sample with subjects affected with job-related exhaustion showed evidence for a GR hypersensitivity, comparable to patients suffering from trauma-related mental disorders.(71,134) In a broader, stimulated expression quantitative trait locus approach, gene expression profiles after GR activation…”
MethodShared Molecular Neuropathology Across Major Psychiatric Disorders Parallels Polygenic Overlap
Gandal, M. J., Haney, J. R., Parikshak, N. N., Leppa, V., Ramaswami, G., Hartl, C., Schork, A. J., Appadurai, V., Buil, A., Werge, T. M., et al. (2019) · Focus · doi:10.1176/appi.focus.17103 · Cited by 195
MicroRNA and Posttranscriptional Dysregulation in Psychiatry
Geaghan, M., & Cairns, M. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.12.009 · Cited by 193
Lin, E., Kuo, P.-H., Liu, Y.-L., Yu, Y. W.-Y., Yang, A. C., & Tsai, S.-J. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00290 · Cited by 191 · cited 2×
“This study could show that deep learning approaches are able to provide tools for distinguishing treatment responders from nonresponders prior to antidepressant treatment.(168) Drug discovery is another field for deep learning application, as it enables bioactivity predictions, synthesis prediction, biological image a…”
BackgroundMethodClinical application of brain imaging for the diagnosis of mood disorders: the current state of play
Savitz, J. B., Rauch, S. L., & Drevets, W. C. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.25 · Cited by 189
Charting the landscape of priority problems in psychiatry, part 1: classification and diagnosis
Stephan, K. E., Bach, D. R., Fletcher, P. C., Flint, J., Frank, M. J., Friston, K. J., Heinz, A., Huys, Q. J. M., Owen, M. J., Binder, E. B., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00361-2 · Cited by 180 · cited 1×
“Instead, the ways patients are diagnosed and treated remained unchanged for decades.(6) In addition, the current diagnostic frameworks with Diagnostic and Statistical Manual of Mental Disorders (DSM) published by the American Psychiatric Association and the International Classification of Diseases (ICD) developed by t…”
BackgroundHow can we realize the promise of personalized antidepressant medicines?
Holsboer, F. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2453 · Cited by 177 · cited 1×
“The aim of precision medicine is to improve the diagnostic process and the choice of a specific treatment using genetic markers or biomarkers derived from peripheral blood, imaging, electroencephalographic measures, or neuropsychological tests (Figure 1).(10,11,13) It has become increasingly clear that the diagnostic…”
BackgroundMenke, A., Arloth, J., Pütz, B., Weber, P., Klengel, T., Mehta, D., Gonik, M., Rex-Haffner, M., Rubel, J., Uhr, M., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.331 · Cited by 177 · cited 1×
“6%.(72) Applying the mDST in a sample with subjects affected with job-related exhaustion showed evidence for a GR hypersensitivity, comparable to patients suffering from trauma-related mental disorders.”
Self-citationExercise programs for people with dementia
Forbes, D., Thiessen, E. J., Blake, C. M., Forbes, S. S., & Forbes, S. (2014) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.20141323t2 · Cited by 177
A Genome-Wide Association Study of Depressive Symptoms
Hek, K., Demirkan, A., Lahti, J., Terracciano, A., Teumer, A., Cornelis, M. C., Amin, N., Bakshis, E., Baumert, J., Ding, J., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.033 · Cited by 172 · cited 1×
“sive symptoms with 34,549 subjects also failed to find significant hits.(25) First significant hits were delivered by Hyde et al investigating self-reported MDD in 75,607 cases; this study identified 15 significantly associated loci.”
BackgroundEmerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications
Dwivedi, Y. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.1/ydwivedi · Cited by 169
Epigenetic alterations in depression and antidepressant treatment
Menke, A., & Binder, E. B. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.3/amenke · Cited by 161
Self-citationCommercial pharmacogenetic-based decision-support tools in psychiatry
Bousman, C., & Hopwood, M. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00017-1 · Cited by 159 · cited 5×
“However, current reviews state that only a small fraction with <20% of the available pharmacogenetic tests has been empirically evaluated, and there are many gaps in the presented evidence.(116,117) In addition, the cost-effectiveness still remains unclear until robust economic studies are conducted.”
BackgroundInfluentialMeta-analysis: Aerobic exercise for the treatment of anxiety disorders
Bartley, C. A., Hay, M., & Bloch, M. H. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.04.016 · Cited by 158
Menke, A., Klengel, T., Rubel, J., Brückl, T., Pfister, H., Lucae, S., Uhr, M., Holsboer, F., & Binder, E. B. (2013) · Genes, Brain and Behavior · doi:10.1111/gbb.12026 · Cited by 151
Self-citationGuilt beyond a reasonable doubt
Altshuler, D., & Daly, M. (2007) · Nature Genetics · doi:10.1038/ng0707-813 · Cited by 151
Predictive analytics in mental health: applications, guidelines, challenges and perspectives
Hahn, T., Nierenberg, A. A., & Whitfield, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.201 · Cited by 150 · cited 2×
“In contrast, machine learning uncovers general concepts underlying a series of observations without explicit instructions.(161,162) Machine learning concepts include”
BackgroundTozzi, L., Farrell, C., Booij, L., Doolin, K., Nemoda, Z., Szyf, M., Pomares, F. B., Chiarella, J., O'Keane, V., & Frodl, T. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.290 · Cited by 146
Arloth, J., Bogdan, R., Weber, P., Frishman, G., Menke, A., Wagner, K. V., Balsevich, G., Schmidt, M. V., Karbalai, N., Czamara, D., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.034 · Cited by 142 · cited 2×
“This approach revealed that common genetic variants that modulate the transcriptional response to GR activation mediate the risk of MDD as well as other mental disorders.(135) Moreover, these risk variants were associated with inappropriate amygdala reactivity to angry and fearful faces.”
BackgroundSelf-citationBetter therapeutics through microarrays
Gerhold, D. L., Jensen, R. V., & Gullans, S. R. (2002) · Nature Genetics · doi:10.1038/ng1042 · Cited by 141 · cited 1×
“variants predisposing to MDD and early adversity as a major environmental factor.(129,130) Common approaches for”
BackgroundEpigenetic programming of the neuroendocrine stress response by adult life stress
Dirven, B. C. J., Homberg, J. R., Kozicz, T., & Henckens, M. J. A. G. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0019 · Cited by 138 · cited 1×
“by modulating translation and mRNA degradation and are involved in the stress response.(58,131) Circulating miRNAs are”
BackgroundWong, E. H. F., Yocca, F., Smith, M. A., & Lee, C.-M. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000866 · Cited by 134
Scarr, E., Millan, M. J., Bahn, S., Bertolino, A., Turck, C. W., Kapur, S., Möller, H.-J., & Dean, B. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv042 · Cited by 132
Neuroimaging-Based Biomarkers in Psychiatry: Clinical Opportunities of a Paradigm Shift
Fu, C. H. Y., & Costafreda, S. G. (2013) · The Canadian Journal of Psychiatry · doi:10.1177/070674371305800904 · Cited by 120
Translating genome-wide association findings into new therapeutics for psychiatry
Breen, G., Li, Q., Roth, B. L., O'Donnell, P., Didriksen, M., Dolmetsch, R., O'Reilly, P. F., Gaspar, H. A., Manji, H., Huebel, C., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4411 · Cited by 118 · cited 1×
“Many efforts are meanwhile in place to translate these genome-wide association findings into new drug targets for mental disorders or to repurpose existing drugs for the treatment of mental disorders that were not initially developed to treat, an approach called drug repositioning.(30,31) For example, the gene HMGCR w…”
BackgroundBerm, E. J. J., Looff, M. D., Wilffert, B., Boersma, C., Annemans, L., Vegter, S., Boven, J. F. M. V., & Postma, M. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146262 · Cited by 115
Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia
Arranz, M. J., Rivera, M., & Munro, J. C. (2011) · CNS Drugs · doi:10.2165/11595380-000000000-00000 · Cited by 112
Genome-wide association studies: a primer
Corvin, A., Craddock, N., & Sullivan, P. F. (2010) · Psychological Medicine · doi:10.1017/s0033291709991723 · Cited by 110
Lopez, J. P., Kos, A., & Turecki, G. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000379 · Cited by 108 · cited 1×
“present in peripheral blood cells and therefore are suitable to serve as predictors for diagnostic evaluations or for treatment response.(58,132,133) A multimodal approach to test the stress hormone system, that is, the HPA axis, in patients with mental disorders is the modified dexamethasone-suppression test (mDST).”
BackgroundHallgren, M., Herring, M. P., Owen, N., Dunstan, D., Ekblom, Ö., Helgadottir, B., Nakitanda, O. A., & Forsell, Y. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00036 · Cited by 107
Applications of blood-based protein biomarker strategies in the study of psychiatric disorders
Chan, M. K., Gottschalk, M. G., Haenisch, F., Tomasik, J., Ruland, T., Rahmoune, H., Guest, P. C., & Bahn, S. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.08.002 · Cited by 101
Exercise Treatment for Depression: Efficacy and Dose Response
Shephard, R. J. (2006) · Yearbook of Sports Medicine · doi:10.1016/s0162-0908(08)70416-1 · Cited by 101
Tran, T., & Kavuluru, R. (2017) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2017.06.010 · Cited by 101
Pharmacogenetics of Antipsychotics
Brandl, E. J., Kennedy, J. L., & Müller, D. J. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900203 · Cited by 99 · cited 1×
“those included in the first pharmacogenetic assays that have been clinically applied.(113,115) Most pharmacogenetic tests”
BackgroundHan, K.-M., Won, E., Sim, Y., Kang, J., Han, C., Kim, Y.-K., Kim, S.-H., Joe, S.-H., Lee, M.-S., Tae, W.-S., et al. (2017) · Scientific Reports · doi:10.1038/srep42621 · Cited by 96
Machine Learning Approaches: From Theory to Application in Schizophrenia
Veronese, E., Castellani, U., Peruzzo, D., Bellani, M., & Brambilla, P. (2013) · Computational and Mathematical Methods in Medicine · doi:10.1155/2013/867924 · Cited by 94
Nassan, M. M., Nicholson, W. T., Elliott, M. A., Vitek, C. R. R., Black, J. L., & Frye, M. A. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.02.023 · Cited by 86 · cited 1×
“to determine if a patient is a normal, an intermediate, a poor, or an ultrarapid metabolizer.(118,119) Therefore, most of the currently commercially available pharmacogenetic tests include variants of these two genes.”
BackgroundPrediction of treatment outcomes in psychiatry—where do we stand ?
McMahon, F. J. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/fmcmahon · Cited by 83
Browning, M., Kingslake, J., Dourish, C. T., Goodwin, G. M., Harmer, C. J., & Dawson, G. R. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.11.1102 · Cited by 83
Fabbri, C., Hosak, L., Mössner, R., Giegling, I., Mandelli, L., Bellivier, F., Claes, S., Collier, D. A., Corrales, A., Delisi, L. E., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1208843 · Cited by 81
van den Bosch, M. A., & Sang, Å. O. (2017) · Journal of Transport & Health · doi:10.1016/j.jth.2017.05.230 · Cited by 81
Müller, D. J., Kekin, I., Kao, A. C. C., & Brandl, E. J. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.838944 · Cited by 80
Epigenetics, Depression and Antidepressant Treatment
Menke, A., Klengel, T., & B. Binder, E. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803523590 · Cited by 77
Self-citationAbandoning personalization to get to precision in the pharmacotherapy of depression
Perlis, R. H. (2016) · World Psychiatry · doi:10.1002/wps.20345 · Cited by 77 · cited 1×
“But as stated above, this “personalization” is highly dependent on the knowledge and experience of the psychiatrist owing a trial and error in variable extend.(12) The aim of precision medicine is to improve the diagnostic process and the choice of a specific treatment using genetic markers or biomarkers derived from…”
BackgroundPersonalized medicine in psychiatry
Wium-Andersen, I. K., Vinberg, M., Kessing, L. V., & McIntyre, R. S. (2017) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2016.1216163 · Cited by 74 · cited 1×
“Implementing these RDocs into biomarker research is now progressively evolving (Figure 1).(15)”
MethodSerretti, A. (2018) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2018.16.1.1 · Cited by 74
Bousman, C. A., Forbes, M., Jayaram, M., Eyre, H., Reynolds, C. F., Berk, M., Hopwood, M., & Ng, C. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1230-5 · Cited by 72 · cited 5×
“However, this variant is not yet routinely included in the available tests.(117) The polygene approach of most of the pharmacogenetic tests is based on evidence that most antidepressants or other psychopharmacologic medications interact with multiple pharmacokinetic and pharmacodynamic pathways.”
BackgroundInfluentialCombined Influence of LDLR and HMGCR Sequence Variation on Lipid-Lowering Response to Simvastatin
Mangravite, L. M., Medina, M. W., Cui, J., Pressman, S., Smith, J. D., Rieder, M. J., Guo, X., Nickerson, D. A., Rotter, J. I., & Krauss, R. M. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.203273 · Cited by 70
Leistner, C., & Menke, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.023 · Cited by 69
Self-citationPandey, D. K., Mahesh, R., kumar, A. A., Rao, V. S., Muralidharan, A., & Rajkumar, R. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.09.018 · Cited by 68
Grabe, H. J., Wittfeld, K., Van der Auwera, S., Janowitz, D., Hegenscheid, K., Habes, M., Homuth, G., Barnow, S., John, U., Nauck, M., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23123 · Cited by 67
ABCB1 gene variants and antidepressant treatment outcome: A meta‐analysis
Breitenstein, B., Brückl, T. M., Ising, M., Müller‐Myhsok, B., Holsboer, F., & Czamara, D. (2015) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32309 · Cited by 66
Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52
Gopalakrishnan, R., Kozany, C., Gaali, S., Kress, C., Hoogeland, B., Bracher, A., & Hausch, F. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201746x · Cited by 64
Fabbri, C., Porcelli, S., & Serretti, A. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900202 · Cited by 63
Hofmann-Apitius, M., Ball, G., Gebel, S., Bagewadi, S., De Bono, B., Schneider, R., Page, M., Kodamullil, A., Younesi, E., Ebeling, C., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226148 · Cited by 55
Childhood trauma dependent anxious depression sensitizes HPA axis function
Menke, A., Lehrieder, D., Fietz, J., Leistner, C., Wurst, C., Stonawski, S., Reitz, J., Lechner, K., Busch, Y., Weber, H., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.07.025 · Cited by 55
Self-citationExploration of pipecolate sulfonamides as binders of the FK506-binding proteins 51 and 52
Gopalakrishnan, R., Kozany, C., Wang, Y., Schneider, S., Hoogeland, B., Bracher, A., & Hausch, F. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201747c · Cited by 52
Kappelmann, N., Lewis, G., Dantzer, R., Jones, P. B., & Khandaker, G. M. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.07.023 · Cited by 51
Markers of gluten sensitivity in acute mania: A longitudinal study
Dickerson, F., Stallings, C. R., Origoni, A. E., Vaughan, C., Khushalani, S., & Yolken, R. H. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.11.007 · Cited by 49
Khambadkone, S. G., Cordner, Z. A., Dickerson, F., Severance, E. G., Prandovszky, E., Pletnikov, M., Xiao, J., Li, Y., Boersma, G. J., Talbot, C. C., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0105-6 · Cited by 48
Kingslake, J., Dias, R., Dawson, G. R., Simon, J., Goodwin, G. M., Harmer, C. J., Morriss, R., Brown, S., Guo, B., Dourish, C. T., et al. (2017) · Trials · doi:10.1186/s13063-017-2247-2 · Cited by 42 · cited 2×
“One example of a smartphone-based application is the Predicting Response to Depression Treatment Test (PReDicT Test).(142) Experimental evidence suggests that patients suffering from MDD are more likely to interpret facial expressions of emotion more negative than matched healthy controls.”
BackgroundMethodSelf-citationLanguage as a biomarker in those at high-risk for psychosis
Rosenstein, M., Foltz, P. W., DeLisi, L. E., & Elvevåg, B. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.04.023 · Cited by 37 · cited 1×
“extracted from social media and analyzed with deep learning techniques to identify subjects at high risk of psychosis.(140) P ha rm ac og en om ic s an d P er so na liz ed M ed ic in e do w nl oa de d fr om h ttp s: //w w w .”
Blood-based biomarkers predicting response to antidepressants
Busch, Y., & Menke, A. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1844-x · Cited by 37
Self-citationAnalysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder
Reinbold, C. S., Forstner, A. J., Hecker, J., Fullerton, J. M., Hoffmann, P., Hou, L., Heilbronner, U., Degenhardt, F., Adli, M., Akiyama, K., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00207 · Cited by 37 · cited 1×
“present in peripheral blood cells and therefore are suitable to serve as predictors for diagnostic evaluations or for treatment response.(58,132,133) A multimodal approach to test the stress hormone system, that is, the HPA axis, in patients with mental disorders is the modified dexamethasone-suppression test (mDST).”
BackgroundMenke, A., Arloth, J., Best, J., Namendorf, C., Gerlach, T., Czamara, D., Lucae, S., Dunlop, B. W., Crowe, T. M., Garlow, S. J., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.04.003 · Cited by 35
Self-citationLovallo, W. R., Enoch, M., Acheson, A., Cohoon, A. J., Sorocco, K. H., Hodgkinson, C. A., Vincent, A. S., & Goldman, D. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.347 · Cited by 33
Binder, E. B. (2017) · European Journal of Psychotraumatology · doi:10.1080/20008198.2017.1412745 · Cited by 29
Menke, A., Arloth, J., Gerber, M., Rex-Haffner, M., Uhr, M., Holsboer, F., Binder, E. B., Holsboer-Trachsler, E., & Beck, J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.02.013 · Cited by 28 · cited 1×
“Applying the mDST in a sample with subjects affected with job-related exhaustion showed evidence for a GR hypersensitivity, comparable to patients suffering from trauma-related mental disorders.(71,134) In a broader, stimulated expression quantitative trait locus approach, gene expression profiles after GR activation…”
MethodSelf-citationGene expression: Biomarker of antidepressant therapy?
Menke, A. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.825580 · Cited by 25 · cited 1×
“variants predisposing to MDD and early adversity as a major environmental factor.(129,130) Common approaches for”
BackgroundSelf-citationOTTO: a new strategy to extract mental disease-relevant combinations of GWAS hits from individuals
Ehrenreich, H., Mitjans, M., der Auwera, S. V., Centeno, T. P., Begemann, M., Grabe, H. J., Bonn, S., & Nave, K. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.208 · Cited by 23
The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders
Severance, E. G., Tveiten, D., Lindström, L., Yolken, R. H., & Reichelt, K. L. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160914183804 · Cited by 22
Winner, J. G., & DeChairo, B. M. (2015) · PubMed · Cited by 21
Arceci, R. J. (2012) · Yearbook of Oncology · doi:10.1016/j.yonc.2012.07.016 · Cited by 20
Association of Western and Traditional Diets With Depression and Anxiety in Women
Ballenger, J. C. (2011) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/j.ypsy.2010.10.069 · Cited by 19
Reconsidering Dietary Polyunsaturated Fatty Acids in Bipolar Disorder: A Translational Picture
Saunders, E. F. H., Ramsden, C. E., Sherazy, M. S., Gelenberg, A. J., Davis, J. M., & Rapoport, S. I. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15com10431 · Cited by 15
Genome-wide association studies: a primer
Corvin, A. P., Sullivan, P. F., & Craddock, N. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/dcne-w697 · Cited by 7
Mehta, D., Gonik, M., Klengel, T., Rex-Haffner, M., Menke, A., Rubel, J., Mercer, K. B., Puetz, B., Bradley, B., Holsboer, F., et al. (2011) · Max Planck Institute for Plasma Physics · Cited by 6
Self-citationBousman, C., Forbes, M., Jayaram, M., Eyre, H. A., Reynolds, C. F., Berk, M., Hopwood, M., & Ng, C. H. (2018) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.16204 · Cited by 5
A Precision Medicine Approach to Antidepressant Treatment in Depression
Dawson, G. R., Kingslake, J., Dourish, C. T., Brammer, M. J., Harmer, C. J., Goodwin, G. M., & Browning, M. D. (2015) · European Neuropsychopharmacology · Cited by 3
Childhood trauma dependent anxious depression sensitizes HPA axis function
Menke, A. (2018) · doi:10.26226/morressier.5b681763b56e9b005965c14b · Cited by 2
Self-citationMenke, A., Arloth, J., Gerber, M., Rex‐Haffner, M., Uhr, M., Holsboer, F., Binder, E., Holsboer‐Trachsler, E., & Beck, J. (2013) · Pharmacopsychiatry · doi:10.1055/s-0033-1353309 · Cited by 1
Self-citation
Research works printed but not linked: 3
- [15]15. Wium-Andersen IK, Vinberg M, Kessing LV, McIntyre RS. Personal- ized medicine in psychiatry. Nord J Psychiatry. 2017;71(1):12-19.
- [113]113. Brandl EJ, Kennedy JL, Müller DJ. Pharmacogenetics of antipsychot- ics. Can J Psychiatry. 2014;59(2):76-88.
- [128]128. Yu S-H, Liu S-K, Lin K-M. Psychopharmacology across cultures. In: Bhugra D, Bhui K, editors. Textbook of Cultural Psychiatry. 1st ed. Cambridge, UK: Cambridge University Press; 2007:402-413.
Cited by
Lee, E. E., Torous, J., De Choudhury, M., Depp, C. A., Graham, S. A., Kim, H.-C., Paulus, M. P., Krystal, J. H., & Jeste, D. V. (2021) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.02.001 · Cited by 429
Jacobs, M., Pradier, M. F., McCoy, T. H., Perlis, R. H., Doshi-Velez, F., & Gajos, K. Z. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01224-x · Cited by 247
Is the HPA Axis as Target for Depression Outdated, or Is There a New Hope?
Menke, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00101 · Cited by 240
“Various factors may explain the current situation: MDD is a heterogeneous condition with poorly defined endophenotypes or subgroups, the currently available drugs have very similar treatment mechanisms and target almost only components of the serotonin, norepinephrine, or dopamine signaling, and there are no biomarker…”
BackgroundSelf-citationJacobs, M., He, J., F. Pradier, M., Lam, B., Ahn, A. C., McCoy, T. H., Perlis, R. H., Doshi-Velez, F., & Gajos, K. Z. (2021) · Proceedings of the 2021 CHI Conference on Human Factors in Computing Systems · doi:10.1145/3411764.3445385 · Cited by 177
“The trial and error involved in identifying effective treatment for a given individual has prompted calls for more integration of evidence-based medicine in the treatment of mental health disorders [40, 48, 58].”
BackgroundThe HPA Axis as Target for Depression
Menke, A. (2024) · Current Neuropharmacology · doi:10.2174/1570159x21666230811141557 · Cited by 131
“To match the patient with the right treatment approach in terms of an individualized treatment, it is necessary to apply tests that assess the function of the HPA axis, such as the dex-CRH test or the molecular DST [14, 47].”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Menke, A.
- Affiliations
- University of Würzburg (DE)
- Corresponding author
- Menke, Andreas
- ORCID
- Menke, Andreas
- Venue
- Pharmacogenomics and Personalized Medicine
- Publisher
- Informa UK Limited
- Published
- 2018-11
- Volume
- Volume 11
- Pages
- 211-222
- ISSN
- 1178-7066 (ISSN-L)
- PMC
- PMC6250105
- OpenAlex
- W2900736680
- Cited by
- 41
- References
- 184
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 5 · 2022: 3 · 2021: 11 · 2020: 11 · 2019: 5
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmacogenomics and Personalized Medicine (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- precision medicine, precision psychiatry, mental illness, pharmacotherapy response, biomarkers, genetic variants, gene-environment interaction, machine learning, artificial intelligence, depression, childhood trauma, FKBP5, electronic health records, neuropsychological assessment, childhood adversity, adverse drug reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.